Pharmacokinetic (PK) studies on recombinant FIX concentrate, Nonacog alpha, were conducted with different sampling time designs which gave rise to not complete and homogenous outcomes. In addition, patient's FIX genotype/PK relationship has never been investigated.
|Numero di pagine||6|
|Stato di pubblicazione||Published - 2016|
All Science Journal Classification (ASJC) codes